Peter McCullough on Covid Prevention
Keeping Clean Where it Counts
The push for prophylaxis and treatment of SARS-CoV-2 oropharyngeal infection starts in the nose and mouth. A randomized trial by Choudhury et al. from Bangladesh has been overlooked by US public agencies but not the early treatment organizations around the world. In this prospective randomized controlled trial, n=606 high-risk subjects with incipient COVID-19 were randomized to 1% povidone-iodine (betadine) solution as a rinse was used for a target of every 4 hours versus lukewarm water for four weeks.
Join us for the next COVID Q & A with Dr. Peter McCullough, on Sept 29, Wednesday, at 6 PM ET, and an encore at 10 PM ET on America Out Loud Talk Radio. Listen on iHeart Radio, our world-class media player, or our free apps on Apple, Android, or Alexa.
what is the protocol for taking Ivermectin to lessen vaccine negative effects if forced to get the covid 19 vaccine?